By The Functional Medicine Report™

Originally published August 7, 2026 in Issue #004 of The Functional Medicine Report™

Six years after COVID-19 changed medicine, the biggest questions aren’t about one man. They’re about how science, public health and healthcare should respond the next time certainty disappears.

Key Takeaways

• Invoking the Fifth Amendment is a constitutional protection, not a finding of guilt or innocence. By itself it answers remarkably few of the questions the public wants answered.
• Accountability and understanding are related goals, but they are not the same goal. An adversarial hearing serves the first well and the second poorly.
• Changing recommendations looked like contradiction to the public. Much of it was the normal process of scientific discovery, compressed into months and watched in real time by billions of people.
• No country excelled across every metric. Success depended entirely on which outcome you were measuring — deaths, hospitalisations, economic performance, education, mental health or civil liberties.
• The hardest damage to repair may be trust. And the patients who never fully recovered are the ones sitting in practices today.

The headlines almost wrote themselves.

“Fauci Pleads the Fifth.”

Within minutes, social media did what it has done so often since 2020. Some declared the testimony proof of guilt. Others dismissed the hearings as political theater. The same divisions that shaped the pandemic quickly resurfaced, with millions of people seeing the same event through completely different lenses.

For many, the conclusion came before the facts.

As healthcare professionals, we should be careful not to make the same mistake.

Invoking the Fifth Amendment isn’t a finding of guilt, nor is it evidence of innocence. It is a constitutional protection that attorneys routinely advise clients to exercise when testimony could expose them to criminal liability. Whether that advice was appropriate in this case isn’t the point. The act of invoking the Fifth, by itself, answers remarkably few of the questions the public wants answered.

That raises a different question.

If the goal is to determine whether crimes were committed, an adversarial hearing makes sense. If the goal is to understand what happened during one of the most consequential public health emergencies in modern history, the process becomes more complicated. Those are related objectives, but they are not the same.

One seeks accountability.

The other seeks understanding.

As clinicians, we should care deeply about both.

COVID-19 affected nearly every aspect of healthcare. It changed how we practiced, how we communicated with patients, how research was shared and how quickly recommendations evolved. It exposed strengths in our healthcare system, but it also revealed weaknesses—in our institutions, in scientific communication and, perhaps most noticeably, in our ability to disagree without assuming bad intent.

It’s tempting to reduce six years of history to a single headline or a single person.

Reality is rarely that simple.

Dr. Anthony Fauci, MD became the public face of America’s pandemic response, but he wasn’t the pandemic. He was one official working within a much larger system that included multiple federal agencies, state governments, researchers, healthcare systems, elected leaders from both political parties and countless scientists around the world. Decisions were made across successive administrations, by thousands of people, often with incomplete information and under extraordinary pressure.

That’s why we believe the most important question isn’t whether today’s headlines vindicate one side or the other.

It’s whether, six years later, we’re finally asking the questions that will make us better prepared for the next pandemic.

Imagine Having That Job

It’s easy to evaluate a crisis after it’s over. It’s much harder to lead through one while it’s unfolding.

In early 2020, the world wasn’t responding to a familiar disease. It was responding to something entirely new. Every day brought more questions than answers. Scientists were racing to understand how the virus spread, who was most at risk, how severe it might become and what, if anything, could slow it down.

Now imagine being one of the people expected to stand behind a podium and answer those questions.

Not next month. Not after the research was complete. That afternoon.

Millions of Americans wanted certainty. Physicians wanted guidance. Hospitals needed protocols. Governors needed recommendations. The White House wanted updates. News organizations demanded answers. Every statement had immediate consequences, and every recommendation would eventually be judged with information that didn’t yet exist.

That’s the challenge of a novel virus.

The word novel isn’t just a scientific description. It’s an acknowledgment that we’re entering unfamiliar territory. There is no playbook. No one has the benefit of hindsight. Decisions must be made using the best available evidence at the time, knowing that the evidence itself is incomplete.

That’s uncomfortable. It’s also how science works.

One of the greatest strengths of science is its willingness to change when better evidence becomes available. Recommendations evolve. Assumptions are challenged. Earlier conclusions are revised or abandoned. In most areas of medicine, we view that process as progress.

During COVID-19, many people interpreted it as inconsistency.

Some recommendations changed because the virus changed. Others changed because researchers learned more. Some changed because early assumptions turned out to be wrong. That isn’t unique to COVID-19. It’s the normal process of scientific discovery, compressed into months instead of years and watched in real time by billions of people.

None of this means every decision was the right one. History should examine those decisions carefully. Some deserve praise. Others deserve criticism. Many will likely remain subjects of debate for years to come.

But if there’s one lesson worth remembering, it’s this: It’s difficult to criticize uncertainty after you’ve been given the answers.

It’s much harder to make decisions before anyone knows what those answers will be.

What We Knew… and What We Didn’t
One of the challenges of looking back at the pandemic is that today’s knowledge quietly replaces yesterday’s uncertainty.

It’s easy to forget just how much was unknown during those first few months.

In January and February of 2020, clinicians around the world were trying to answer questions that simply didn’t have answers yet.

How contagious was this virus?

Could people spread it before they developed symptoms?

How long did immunity last after infection?

Would it behave like influenza, SARS or something entirely different?

Would older adults be the only population at greatest risk, or would healthy young people also become critically ill?

Would vaccines be possible?

Would antiviral medications work?

Could people recover completely, or would there be lasting complications?

None of those questions had clear answers. Yet decisions couldn’t wait until the science was settled.

Hospitals needed protocols. Clinics needed guidance. Governments had to make policy decisions.

Healthcare professionals had to advise patients who were looking for certainty in a situation where certainty simply didn’t exist.

Over the months and years that followed, many of those questions were answered—or at least answered more completely.

Researchers gained a better understanding of airborne transmission. It became increasingly clear that older adults and people with certain underlying medical conditions were at substantially higher risk of severe disease. Vaccines were developed in record time and were shown to reduce severe illness and hospitalization for many populations, even as their effectiveness against infection changed with emerging variants. Long COVID, which was barely recognized early in the pandemic, became a major area of clinical research. Treatments improved. Clinical protocols evolved.

That’s what science is supposed to do. It learns. It corrects itself. It adapts when better evidence becomes available.

Unfortunately, much of the public experienced those changes very differently.

To many people, changing recommendations looked like contradiction rather than discovery. Advice that evolved over months was interpreted as evidence that experts had been dishonest, when in many cases it reflected the normal process of learning more about a rapidly changing disease.

Of course, not every recommendation changed simply because new evidence emerged. Some decisions deserve ongoing scrutiny. Some policies may ultimately prove to have caused more harm than benefit. Others likely prevented illness and saved lives. Those conversations should continue—and they should.

But they’re most productive when we distinguish between decisions made with incomplete information and decisions made after better evidence became available.

Those are not the same thing.

Perhaps that’s one of the most important lessons COVID-19 leaves us with. Science is not a collection of permanent answers. It’s a process for finding better ones.

Early 2020	What We Understand Today
Limited understanding of asymptomatic spread	Asymptomatic and presymptomatic transmission played a significant role.
Surface transmission was a major concern	Airborne transmission is now understood to be the dominant route in most settings.
Long COVID was largely unrecognized	Persistent post-viral symptoms are now widely studied and acknowledged.
No proven treatments or vaccines	Multiple vaccines and therapies were developed, while treatment protocols evolved substantially.

The World Didn’t Respond One Way

One of the easiest mistakes to make when looking back at COVID-19 is assuming there were only two choices.

There weren’t.

While the debate in the United States often feels divided into competing political narratives, the rest of the world tells a far more complicated story.

Every country was trying to answer the same question:

How do you protect lives when you’re facing a virus no one fully understands?

The answers were remarkably different.

Sweden became known for taking a comparatively less restrictive approach, relying more heavily on voluntary measures than mandatory lockdowns. New Zealand pursued one of the world’s strictest elimination strategies, closing its borders early and imposing aggressive lockdowns in an effort to stop community transmission. China maintained its “Zero COVID” policy for years, using extensive testing, quarantines and movement restrictions before ultimately abandoning that approach. South Korea focused heavily on testing, contact tracing and rapid public health response while avoiding some of the prolonged nationwide shutdowns seen elsewhere. Even within the United States, states often adopted dramatically different policies despite facing the same virus.

No two approaches produced identical outcomes.

Some countries experienced lower mortality during certain phases of the pandemic. Others preserved more economic activity. Some protected hospital capacity more effectively. Others accepted greater viral spread in exchange for fewer societal restrictions. Many countries saw their outcomes change over time as new variants emerged, vaccination rates differed and public compliance evolved.

That’s what makes simplistic conclusions so difficult.

Success depended on which outcome you were measuring.

Were you measuring deaths?

Hospitalizations?

Economic performance?

Educational disruption?

Mental health?

Civil liberties?

Healthcare access?

Each metric tells a different story. There was no strategy that excelled across every category.

That’s an uncomfortable reality because people naturally prefer clear winners and clear losers. But public health rarely works that way. Every major decision involves tradeoffs, and those tradeoffs often become fully visible only years later.

Perhaps the most important lesson isn’t that one country got everything right while another got everything wrong.

It’s that every nation was forced to make extraordinarily difficult decisions with incomplete information, different healthcare systems, different cultures, different political structures and different public expectations.

Looking back with six years of additional data doesn’t eliminate that complexity.

If anything, it reminds us just how complex the problem always was.

Country/Region	Primary Strategy	Potential Strength	Potential Tradeoff
Sweden	Fewer mandatory restrictions	Greater continuity of daily life	Higher mortality than some Nordic neighbors during early waves
New Zealand	Elimination strategy	Very low early case counts and deaths	Long border closures and economic/social disruption
China	Zero COVID	Delayed widespread transmission for a period	Extensive restrictions and difficult exit from the strategy
South Korea	Testing, tracing, targeted response	Rapid outbreak detection	Sustained public health infrastructure demands
United States	State-by-state approaches	Policy flexibility	Highly variable outcomes and significant public polarization

When Science Meets Politics

Medicine and politics have always influenced one another.

COVID-19 made them inseparable.

Public health officials were no longer speaking only to physicians or researchers. Every recommendation was delivered into an environment shaped by political debate, 24-hour news cycles and social media algorithms designed to reward certainty over nuance.

That created a problem. Science rarely speaks in absolutes.

A good scientist is comfortable saying, “Here’s what we know today.” Equally important, they’re willing to say, “Here’s what we don’t know yet.” As new evidence emerges, conclusions change. That’s not a flaw in the scientific process—it’s one of its greatest strengths.

Politics works differently.

Political leaders are expected to project confidence, make decisions quickly and reassure the public. Hesitation is often interpreted as weakness. Uncertainty can be perceived as indecision.

The media adds another layer. Complex scientific discussions don’t always translate into headlines. “More research is needed” rarely attracts the same attention as a definitive statement, even when the more cautious message is the more accurate one.

When those three worlds—science, politics and media—collide during a global emergency, tension is almost inevitable.

Recommendations evolve because the evidence evolves. Political leaders want clear answers. The public wants certainty.

The result is that changing guidance, something scientists expect and even welcome, can be interpreted as incompetence, inconsistency or deception.

Perhaps that’s one reason the pandemic became so polarizing.

Many people weren’t simply evaluating the evidence. They were evaluating it through political identity, personal experience, economic hardship, fear for loved ones and an information ecosystem that often rewarded outrage over nuance.

It’s understandable why emotions ran high.

Families lost loved ones.

Businesses closed.

Healthcare workers experienced extraordinary levels of burnout.

Children missed school.

Patients delayed preventive care.

The consequences were real, and they were deeply personal.

But if medicine is going to learn from this period, we have to separate two different questions.

Were some decisions wrong? Almost certainly. No response to a once-in-a-century pandemic will be perfect.

Should those decisions be examined honestly? Absolutely. That’s how medicine improves.

The challenge is making sure those conversations are driven by evidence rather than ideology.

Because once every scientific question becomes a political question, it becomes much harder to hear new evidence—even when it’s good evidence.

And that’s a lesson worth remembering long after the headlines surrounding Dr. Fauci have faded.

The Cost of Polarization

Every major public health event leaves a legacy. COVID-19 left several.

It accelerated vaccine technology. It expanded telemedicine. It transformed how quickly scientific research could be shared across the globe. It also exposed weaknesses in supply chains, emergency preparedness and public health communication that will likely shape policy for years to come.

But there was another consequence that may prove even more difficult to repair.

Trust.

Not just trust in government or public health agencies. Trust between patients and practitioners. Trust between colleagues. Trust in science itself.

Before the pandemic, most patients assumed that if they sought opinions from multiple physicians, those physicians would generally agree on the fundamentals of care. During COVID-19, many discovered something they had never experienced before: intelligent, well-trained clinicians looking at the same evidence and reaching different conclusions.

For some patients, that was unsettling. For others, it was confusing. For many practitioners, it was exhausting.

Professional disagreements are not new. Medicine has always evolved through debate. New evidence challenges established thinking, and today’s standard of care often replaces yesterday’s best practice. That’s how healthcare advances.

What changed during the pandemic was the environment in which those disagreements occurred.

Scientific debates that would normally unfold over years in medical journals were suddenly happening in real time, in front of millions of people, on cable news and social media. Every new study was immediately celebrated, criticized or politicized before the scientific community had time to evaluate it in the broader context of the growing evidence.

Nuance became difficult to find.

Social media rewarded certainty. Television rewarded conflict. Algorithms rewarded engagement. Unfortunately, the fastest way to generate engagement is often to convince people that someone else is completely wrong.

Medicine rarely works that way.

Most clinical questions exist on a spectrum of probability, not certainty. Recommendations evolve because new evidence emerges, not because science has failed.

Yet as the months passed, it became increasingly common to view every disagreement as evidence that someone was acting in bad faith. Colleagues questioned one another’s motives. Patients questioned their physicians. Physicians questioned public health officials. Public health officials questioned clinicians who departed from mainstream recommendations.

The result wasn’t simply disagreement. It was division.

That division carried a cost extending far beyond the pandemic itself. Once trust begins to erode, it doesn’t automatically return when the crisis ends. Patients become more skeptical. Clinicians become more cautious. Public health messages become more difficult to communicate, even when the evidence supporting them is strong.

Perhaps that’s the greatest lesson hiding beneath the headlines surrounding Dr. Fauci’s testimony.

The lasting challenge isn’t deciding who won the argument.

It’s rebuilding enough trust that, when the next public health emergency arrives, we can have difficult scientific conversations without immediately assuming the worst about one another.

What Functional Medicine Should Learn

If there’s one lesson the pandemic reinforced, it’s that medicine is rarely as simple as we’d like it to be. Patients don’t arrive carrying a diagnosis. They arrive carrying uncertainty.

Long before COVID-19, functional medicine practitioners had become accustomed to working in that space. A patient presents with fatigue, brain fog or chronic pain, and the answer isn’t immediately obvious. We take a history. We ask different questions. We gather data. We test. We interpret. We adjust. As new information emerges, the care plan evolves.

In many ways, that same mindset should guide how we look back on the pandemic.

The goal shouldn’t be to defend every decision that was made, nor should it be to assume every decision was wrong. The goal should be to ask better questions than we asked six years ago.

What did we get right?

What did we misunderstand?

What assumptions deserve to be challenged?

What evidence has become stronger?

Where are the gaps that still deserve honest investigation?

Those aren’t signs of weakness. They’re signs of scientific maturity.

One of the healthiest things a clinician can say is, “Based on what we know today…” Those six words acknowledge something every good practitioner understands: today’s understanding may not be tomorrow’s understanding. That’s true in endocrinology. It’s true in gastroenterology. It’s true in infectious disease. And it will be true during the next public health emergency.

Patients don’t expect us to predict the future. They expect us to be thoughtful, honest and willing to change course when the evidence changes.

Perhaps that’s where functional medicine has the greatest opportunity to contribute. Not by claiming certainty. Not by becoming more political.

But by modeling intellectual humility—the willingness to follow the evidence, even when it leads somewhere unexpected.

In the years ahead, the profession won’t be judged by whether it won an argument about COVID-19.

It will be judged by whether it learned enough from the experience to care for the next patient—and the next pandemic—with greater wisdom than the last.

Looking Ahead
One day there will be another novel virus.

It may not look like COVID-19. It may spread differently, affect different populations or require a completely different public health response. But when it arrives, healthcare professionals will once again face the same challenge: making important decisions before every answer is known.

That’s the reality of practicing medicine.

We rarely have perfect information. We work with the best evidence available, remain open to new discoveries and adjust our thinking as that evidence evolves. That isn’t a weakness in science. It’s the very reason science continues to move forward.

Perhaps that’s why the conversation surrounding the Fauci hearings feels incomplete.

Whether history ultimately judges individual decisions favorably or critically, the larger questions remain. Have we become better at communicating uncertainty?

Have we learned how to separate scientific debate from political identity? Can we disagree professionally without assuming bad intentions?

Have we created an environment where researchers, clinicians and public health leaders can revise their recommendations as evidence evolves without immediately losing public trust?

Those questions matter far beyond COVID-19.

They will shape how we respond to the next pandemic, the next emerging infectious disease and the next public health emergency that forces medicine to make difficult decisions under extraordinary pressure.

For functional medicine practitioners, there may be one additional lesson worth carrying forward. Our role has never been to have every answer. Our responsibility is to keep asking better questions. To remain curious. To follow the evidence wherever it leads. To acknowledge uncertainty without becoming paralyzed by it.

And to remember that today’s best understanding may continue to evolve tomorrow.

If the past six years have taught us anything, it’s that certainty is often temporary.

Humility, however, never goes out of style.

Dr. Z’s Take

Six years later, I’m honestly less interested in relitigating every decision that was made during COVID-19 than I am in understanding what we should learn from it.

I don’t know Dr. Fauci personally, and I certainly don’t envy the position he’s in today. Leading through a once-in-a-century pandemic (I hope!) had to be one of the most difficult jobs in medicine. Whether history ultimately judges some decisions as right, wrong or somewhere in between, I suspect very few people would volunteer to trade places with him.

What has fascinated me most hasn’t been one person or one policy. It’s been watching how differently countries around the world responded—and what we can learn from those differences. No two healthcare systems made exactly the same choices. No country got everything right. Every approach came with tradeoffs that we’re still trying to understand.

As a functional medicine practitioner, my attention has gradually shifted somewhere else entirely.

I’m far more interested in the patients who never fully recovered.

The post-viral fatigue. The dysautonomia. The chronic inflammation. The immune dysregulation. The people who still don’t feel like themselves years later. Those are the patients sitting in our practices today, and they’re the reason I believe our greatest opportunity is no longer arguing about the past—it’s improving how we care for the future.

If I’m being honest, I worry that we’ve become better at choosing sides than asking questions.

Medicine doesn’t move forward because everyone agrees. It moves forward because people remain curious enough to keep testing ideas, humble enough to change their minds and willing enough to collaborate when new evidence emerges.

The media will always have headlines. Social media will always have opinions. Our responsibility is different.

It’s to keep learning.

If a new pandemic popped up in the next year, I think we’d be in trouble. I hope it is far enough off that we have some time to become less divided and more collaborative before we are again tested.

I also think it’s important to remember why this conversation still feels so raw.

COVID wasn’t just a scientific event. It was a deeply personal one. Nearly everyone can point to something they lost—a loved one, a business, years of normal life, their health, or simply their trust in institutions they once believed in.

When people carry that kind of loss, they don’t debate the pandemic as an abstract policy discussion. They debate it through the lens of their own experience. Maybe that’s why these conversations still feel so difficult. Before we judge one another too quickly, it’s worth remembering that almost everyone is bringing a different story to the table.

FAQ

Sources

The article makes factual claims about a named hearing and does not currently cite it. These four cover the event itself. Hyperlink each URL — bare text is not crawlable as a link.

• Senate Homeland Security and Governmental Affairs Committee hearing on COVID-19 origins, 29 July 2026. Coverage: PBS NewsHour. https://www.pbs.org/newshour/show/fauci-invokes-5th-amendment-right-during-gop-led-hearing-on-covid-origins
• “Dr. Anthony Fauci repeatedly invokes the Fifth in dramatic Senate hearing about Covid pandemic.” CNN, 29 July 2026. https://www.cnn.com/2026/07/29/politics/anthony-fauci-fifth-amendment-plea
• “Anthony Fauci invokes Fifth Amendment in Rand Paul Senate hearing.” NPR, 29 July 2026. https://www.npr.org/2026/07/29/nx-s1-5910542/fauci-rand-paul-diary-coronavirus-origin-lab-leak-hearing
• “Why did Anthony Fauci invoke the Fifth Amendment? Senate hearing explained.” Al Jazeera, 30 July 2026. https://www.aljazeera.com/news/2026/7/30/why-did-anthony-fauci-invoke-the-fifth-amendment-senate-hearing-explained